Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. ERYTECH Pharma S.A.
  6. News
  7. Summary
    ERYP   FR0011471135

ERYTECH PHARMA S.A.

(ERYP)
  Report
Real-time Euronext Paris  -  11:35 2022-12-06 am EST
0.6250 EUR   -0.48%
12/01European Equities Move Higher Thursday as EU Nears Cap on Russian Oil
MT
11/22Transcript : ERYTECH Pharma S.A., Q3 2022 Earnings Call, Nov 22, 2022
CI
11/21ERYTECH Provides Business and Financial Update for the Third Quarter of 2022
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Fall in Friday Trading

09/23/2022 | 11:55am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ACHILLES CORPORATION -1.06% 1309 Delayed Quote.5.92%
ACHILLES THERAPEUTICS PLC -11.26% 1.525 Delayed Quote.-65.87%
CELLECTIS S.A. 1.48% 2.198 Real-time Quote.-70.89%
CREDIT SUISSE GROUP AG -2.57% 2.956 Delayed Quote.-63.87%
DBV TECHNOLOGIES -4.02% 2.578 Real-time Quote.-12.19%
ERYTECH PHARMA S.A. -0.48% 0.625 Real-time Quote.-70.38%
MIDATECH PHARMA PLC 0.00% 5.85 Delayed Quote.-67.95%
MYNARIC AG -1.32% 15 Delayed Quote.-67.21%
NUCANA PLC -6.91% 0.8099 Delayed Quote.-63.45%
OPERA LIMITED -1.14% 5.22 Delayed Quote.-28.33%
SILENCE THERAPEUTICS PLC 30.00% 3.25 Delayed Quote.0.00%
TC BIOPHARM (HOLDINGS) PLC 0.83% 4.88 End-of-day quote.0.00%
TRINITY BIOTECH PLC -1.13% 1.2754 Delayed Quote.-9.79%
All news about ERYTECH PHARMA S.A.
12/01European Equities Move Higher Thursday as EU Nears Cap on Russian Oil
MT
11/22Transcript : ERYTECH Pharma S.A., Q3 2022 Earnings Call, Nov 22, 2022
CI
11/21ERYTECH Provides Business and Financial Update for the Third Quarter of 2022
GL
11/21ERYTECH Provides Business and Financial Update for the Third Quarter of 2022
AQ
11/21ERYTECH Pharma S.A. Reports Earnings Results for the Nine Months Ended September 30, 20..
CI
11/18Pharmaceutical Stocks Help European Equities Nudge Higher to End Quiet Week
MT
11/15European Markets Move Higher Helped by Upbeat US Inflation Data
MT
11/14European ADRs Continue to Trend Higher in Monday Trading
MT
11/11European ADRs Move Slightly Lower in Friday Trading
MT
11/08European ADRs Move Higher in Tuesday Trading, Adding to Monday's Gains
MT
More news
Analyst Recommendations on ERYTECH PHARMA S.A.
More recommendations
Financials
Sales 2022 9,20 M 9,68 M 9,68 M
Net income 2022 -52,8 M -55,5 M -55,5 M
Net Debt 2022 1,50 M 1,58 M 1,58 M
P/E ratio 2022 -0,28x
Yield 2022 -
Capitalization 19,4 M 20,4 M 20,4 M
EV / Sales 2022 2,27x
EV / Sales 2023 1,45x
Nbr of Employees 149
Free-Float 98,5%
Chart ERYTECH PHARMA S.A.
Duration : Period :
ERYTECH Pharma S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ERYTECH PHARMA S.A.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus SELL
Number of Analysts 1
Last Close Price 0,63 €
Average target price 3,60 €
Spread / Average Target 473%
EPS Revisions
Managers and Directors
Gil Beyen Chief Executive Officer & Director
Eric Soyer Chief Operating & Financial Officer
Jean-Paul Kress Chairman
Iman El-Hariry Chief Medical Officer
Stewart Craig Chief Technical Officer
Sector and Competitors
1st jan.Capi. (M$)
ERYTECH PHARMA S.A.-70.38%20
VERTEX PHARMACEUTICALS46.34%82 493
REGENERON PHARMACEUTICALS, INC.21.36%81 852
BIONTECH SE-35.33%41 250
WUXI APPTEC CO., LTD.-34.04%32 901
GENMAB A/S24.18%30 145